Application Due Date Changes for RFA-HL-23-013, "Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)"
National Institutes of Health
Posted on:
Tipo
Research/project funding
Notice NOT-HL-22-018 from the NIH Guide for Grants and Contracts